Results 101 to 110 of about 878,311 (236)
Coronary reaccess can be difficult after valve-in-valve transcatheter aortic valve replacement. We present a case whereby prior valve-in-valve transcatheter aortic valve replacement created difficulty with coronary reaccess.
Craig Basman, MD +4 more
doaj +1 more source
The first experience of implantation of the transcatheter aortal valve prosthesis “MedLab-KT”
Aim. Transcatheter aortic valve replacement in patients with high and extremely high risk has become a routine procedure in many cardiac surgery clinics. Until recently, there were no transcatheter prostheses produced within Russia. This article analyzes
A. V. Bogachev-Prokofiev +3 more
doaj +1 more source
Transcatheter Aortic Valve Replacement in Transition
In this issue of JACC: Cardiovascular Interventions , De Backer et al. [(1)][1] describe the evolving trends in aortic valve replacement (AVR), both surgical AVR (SAVR) and transcatheter AVR (TAVR), for aortic stenosis over the past decade.
John G, Webb, Sandra, Lauck
openaire +2 more sources
Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet +4 more
wiley +1 more source
Predicting mortality after transcatheter aortic valve replacement external validation of the Transcatheter Valve Therapy registry model [PDF]
BACKGROUND: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement.
Oliver Muller +34 more
core +4 more sources
Bicuspid Aortic Valve Disease: Classifications, Treatments, and Emerging Transcatheter Paradigms
Bicuspid aortic valve (BAV) is a common congenital valvular malformation, which may lead to early aortic valve disease and bicuspid-associated aortopathy. A novel BAV classification system was recently proposed to coincide with transcatheter aortic valve
Ankur Kalra, MD +11 more
doaj +1 more source
Transcatheter Aortic and Mitral Valve Replacements
Amid rapid growth in transcatheter valvular interventions computed tomography (CT) has emerged as a pivotal noninvasive imaging resource that can be used throughout many stages of the transcatheter heart valve process, enhancing procedural success and efficacy. It affords a three-dimensional assessment of the aortic and challenging saddle-shaped mitral
Wilson, Ryan +5 more
openaire +3 more sources
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz +7 more
wiley +1 more source
Novel dedicated devices allow transcatheter treatment of pure aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System was introduced as the first dedicated and on-label AR transcatheter aortic valve replacement system, implementing a locator ...
Jonathan Curio, MD +10 more
doaj +1 more source
A Reassessment of Prophylactic Antibiotics in Low‐Infection‐Risk Electrophysiology Procedures
ABSTRACT Certain electrophysiology (EP) procedures are associated with minimal tissue disruption and do not involve permanent transvenous leads. As a result, these interventions carry a lower risk of device‐ or procedure‐related infection. These procedures include placement of implantable cardiac monitors, leadless pacemakers, and left atrial appendage
Rahel M. Sileshi +14 more
wiley +1 more source

